Used in biomedical research to quantify levels of UCHL1 protein in biological samples such as tissue lysates, cerebrospinal fluid, and cell culture supernatants. Helps in studying neurodegenerative diseases like Parkinson's and Alzheimer's, as UCHL1 is abundant in neurons and involved in protein degradation pathways. Also applied in cancer research, particularly in lung and breast cancer, where UCHL1 expression may serve as a potential biomarker. The kit enables high-throughput, sensitive, and specific detection, supporting both clinical and preclinical investigations.